1
|
Albert J, Janabi BA, Granell J, Hashemi MS, Sainz D, Khosa MK, Calvis C, Messeguer R, Baldomà L, Badia J, Font-Bardia M. Synthesis and biological properties of palladium(II) cyclometallated compounds derived from (E)-2-((4-hydroxybenzylidene)amino)phenol. J Organomet Chem 2022. [DOI: 10.1016/j.jorganchem.2022.122555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
2
|
Lu X, Du G, Zhang Z, Gong G, Cai W, Wu L, Zhao G. Fabrication of Redox‐ and pH‐Sensitive Self‐Assembled Nano‐Micelles with Pegylated
β
‐Cyclodextrin for Codelivery of Doxorubicin and Cyclopalladated Ferrocene. Eur J Inorg Chem 2022. [DOI: 10.1002/ejic.202101061] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Xiangyu Lu
- College of Chemical Engineering Sichuan University 610065 Chengdu P. R. China
| | - Guoyuan Du
- College of Chemical Engineering Sichuan University 610065 Chengdu P. R. China
| | - Zhonghui Zhang
- College of Chemical Engineering Sichuan University 610065 Chengdu P. R. China
| | - Guidong Gong
- College of Chemical Engineering Sichuan University 610065 Chengdu P. R. China
| | - Wentao Cai
- College of Chemical Engineering Sichuan University 610065 Chengdu P. R. China
| | - Liji Wu
- College of Chemical Engineering Sichuan University 610065 Chengdu P. R. China
| | - Gang Zhao
- College of Chemical Engineering Sichuan University 610065 Chengdu P. R. China
| |
Collapse
|
3
|
Zalevskaya O, Gur'eva Y, Kutchin A, Aleksandrova Y, Yandulova E, Nikolaeva N, Neganova M. Palladium complexes with terpene derivatives of ethylenediamine and benzylamine: Synthesis and study of antitumor properties. Inorganica Chim Acta 2021. [DOI: 10.1016/j.ica.2021.120593] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
4
|
Shahsavari HR, Hu J, Chamyani S, Sakamaki Y, Babadi Aghakhanpour R, Salmon C, Fereidoonnezhad M, Mojaddami A, Peyvasteh P, Beyzavi H. Fluorinated Cycloplatinated(II) Complexes Bearing Bisphosphine Ligands as Potent Anticancer Agents. Organometallics 2020; 40:72-82. [PMID: 34334870 DOI: 10.1021/acs.organomet.0c00728] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
A family of cationic cycloplatinated(II) complexes [Pt(dfppy)(P^P)]Cl, dfppy = 2-(2,4-difluorophenyl)pyridine, incorporating bisphosphine ligands, P^P = bis(diphenylphosphino)methane (1, dppm), 1,2-bis(diphenylphosphino)ethane (2, dppe) and 1,2-bis(diphenylphosphino)benzene (3, dppbz), was prepared. The complexes were characterized by means of several analytical and spectroscopic methods. These complexes displayed acceptable stability in the biological environments which was confirmed by NMR, HR ESI-MS and UV-vis techniques. The antiproliferative properties of these complexes were evaluated by National Cancer Institute (NCI) at National Institutes of Health (NIH) against 60 different human tumor cell lines such as leukemia, melanoma, lung, colon, brain, ovary, breast, prostate and kidney. These complexes showed higher cytotoxicity than cisplatin against a wide variety of cancer cell lines such as K-562 (leukemia), HOP-92 (lung), HCT-116 (colon), OVCAR-8 (ovarian), PC-3 (prostate), MDA-MB-468 (breast), and melanoma cancer cell lines. Complex 3 as the most potent compound in this study furnished an excellent anti-proliferative activity compared to the cisplatin against Hela, SKOV3, and MCF-7 cancer cell lines. The main mode of the interaction of 1-3 with DNA was also determined using molecular docking studies.
Collapse
Affiliation(s)
- Hamid R Shahsavari
- Department of Chemistry, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, 45137-66731, Iran; Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, 72701, United States
| | - Jiyun Hu
- Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, 72701, United States
| | - Samira Chamyani
- Department of Chemistry, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, 45137-66731, Iran
| | - Yoshie Sakamaki
- Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, 72701, United States
| | - Reza Babadi Aghakhanpour
- Department of Chemistry, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, 45137-66731, Iran
| | - Christopher Salmon
- Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, 72701, United States
| | - Masood Fereidoonnezhad
- Department of Medicinal Chemistry, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, 61357-15794, Iran
| | - Ayyub Mojaddami
- Department of Medicinal Chemistry, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, 61357-15794, Iran
| | - Parnian Peyvasteh
- Department of Medicinal Chemistry, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, 61357-15794, Iran
| | - Hudson Beyzavi
- Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, 72701, United States
| |
Collapse
|
5
|
Organometallic binuclear Pd(II) complex: Synthesis, crystal structure and in-vitro antitumor activity study. INORG CHEM COMMUN 2019. [DOI: 10.1016/j.inoche.2019.05.017] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
6
|
Vojtek M, Marques MPM, Ferreira IMPLVO, Mota-Filipe H, Diniz C. Anticancer activity of palladium-based complexes against triple-negative breast cancer. Drug Discov Today 2019; 24:1044-1058. [PMID: 30849441 DOI: 10.1016/j.drudis.2019.02.012] [Citation(s) in RCA: 69] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2018] [Revised: 01/17/2019] [Accepted: 02/28/2019] [Indexed: 12/24/2022]
Abstract
Treatment of triple-negative breast carcinoma (TNBC) remains an unmet medical need with no targeted therapy available to date. Accounting for 10-30% of all human breast cancer tumors, this mammary carcinoma subtype has a particularly poor prognosis owing to its high metastatic potential, aggressive biology and limited pharmacological treatment options. Platinum chemotherapeutics are the mainstay therapy in patients with TNBC but their clinical use is limited by severe toxicity and acquired resistance. Palladium-based complexes are appealing alternative metal-based drugs because of significant similarities regarding structure and coordination chemistry with the platinum agents. This review summarizes the knowledge gathered so far on 121 Pd(II) complexes, emphasizing their anticancer activity and putative pharmacological targets toward TNBC.
Collapse
Affiliation(s)
- Martin Vojtek
- LAQV/REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - Maria P M Marques
- Unidade de I&D "Química-Física Molecular", Department of Chemistry, University of Coimbra, Coimbra, Portugal; Department of Life Sciences, University of Coimbra, Coimbra, Portugal
| | - Isabel M P L V O Ferreira
- LAQV/REQUIMTE, Laboratory of Bromatology and Hydrology, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - Hélder Mota-Filipe
- iMed.ULisboa, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
| | - Carmen Diniz
- LAQV/REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.
| |
Collapse
|
7
|
Karami K, Jamshidian N, Zakariazadeh M. Synthesis, characterization and molecular docking of newC,N-palladacycles containing pyridinium-derived ligands: DNA and BSA interaction studies and evaluation as anti-tumor agents. Appl Organomet Chem 2019. [DOI: 10.1002/aoc.4728] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Kazem Karami
- Department of Chemistry; Isfahan University of Technology; Isfahan 84156/83111 Iran
| | - Nasrin Jamshidian
- Department of Chemistry; Isfahan University of Technology; Isfahan 84156/83111 Iran
| | - Mostafa Zakariazadeh
- Research Institute for Fundamental Sciences (RIFS); University of Tabriz; Tabriz Iran
| |
Collapse
|
8
|
Solé M, Balcells C, Crespo M, Quirante J, Badia J, Baldomà L, Font-Bardia M, Cascante M. Synthesis, characterization and biological activity of new cyclometallated platinum(iv) complexes containing a para-tolyl ligand. Dalton Trans 2018; 47:8956-8971. [PMID: 29922789 DOI: 10.1039/c8dt01124a] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
The synthesis of three new cyclometallated platinum(ii) compounds containing a para-tolyl ligand and a tridentate [C,N,N'] (cm1) or a bidentate [C,N] ligand and an additional ligand such as SEt2 (cm2) or PPh3 (cm3) is reported. The X-ray molecular structure of platinum(ii) compound cm3 is also presented. Intermolecular oxidative addition of methyl iodide or iodine upon cm1, cm2 and cm3 produced six novel cyclometallated platinum(iv) compounds. The cytotoxic activity against a panel of human adenocarcinoma cell lines (A-549 lung, MDA-MB-231 and MCF-7 breast, and HCT-116 colon), DNA interaction, topoisomerase I, IIα, and cathepsin B inhibition, and cell cycle arrest, apoptosis and ROS generation of the investigated complexes are presented. The best results for antiproliferative activity were obtained for platinum(iv) compounds cm1MeI and cm1I2 arising from oxidative addition of methyl iodide and iodine, respectively, to cm1. Cyclometallated platinum(iv) compounds cm1MeI and cm3MeI induce significant changes in the mobility of DNA and, in addition, cm1MeI, cm3MeI and cm1I2, showed considerable topoisomerase IIα inhibitory activity. Moreover, the compounds exhibiting the higher antiproliferative activity (cm1MeI and cm1I2) were found to generate ROS and to supress HCT-116 colon cancer cell growth by a mixture of cell cycle arrest and apoptosis induction. 1H NMR experiments carried out in a buffered aqueous medium (pH 7.40) indicate that compound cm1MeI is not reduced by common biologically relevant reducing agents such as ascorbic acid, glutathione or cysteine.
Collapse
Affiliation(s)
- Mònica Solé
- Departament de Química Inorgànica i Orgànica, Secció de Química Inorgànica, Facultat de Química, Universitat de Barcelona, Diagonal 645, 08028-Barcelona, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Gong G, Cao Y, Wang F, Zhao G. Planar Chiral Ferrocene Cyclopalladated Derivatives Induce Caspase-Dependent Apoptosis and Antimetastasis in Cancer Cells. Organometallics 2018. [DOI: 10.1021/acs.organomet.7b00897] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Guidong Gong
- College of Chemical Engineering, Sichuan University, Chengdu 610064, PR China
| | - Yuan Cao
- College of Chemical Engineering, Sichuan University, Chengdu 610064, PR China
| | - Fei Wang
- Key Laboratory of Natural Medicine and Clinical Translation, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, PR Chian
| | - Gang Zhao
- College of Chemical Engineering, Sichuan University, Chengdu 610064, PR China
| |
Collapse
|
10
|
Blanckenberg A, Aliwaini S, Kimani S, van Niekerk A, Neumann-Mufweba A, Prince S, Mapolie S. Preparation, characterization and evaluation of novel 1,3,5-triaza-7-phosphaadamantane (PTA)-based palladacycles as anti-cancer agents. J Organomet Chem 2017. [DOI: 10.1016/j.jorganchem.2017.09.005] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|
11
|
Endo and exo cyclopalladated ( E )- N -([1,1'-biphenyl]-2-yl)-1-mesitylmethanimines: Anticancer, antibacterial and antioxidant activities. J Organomet Chem 2017. [DOI: 10.1016/j.jorganchem.2017.04.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
12
|
Novel Palladium(II) Complexes that Influence Prominin-1/CD133 Expression and Stem Cell Factor Release in Tumor Cells. Molecules 2017; 22:molecules22040561. [PMID: 28358339 PMCID: PMC6154565 DOI: 10.3390/molecules22040561] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2017] [Revised: 03/19/2017] [Accepted: 03/23/2017] [Indexed: 01/18/2023] Open
Abstract
New Pd(II) complexes of 1,7-bis(2-methoxyphenyl)hepta-1,6-diene-3,5-dione were synthesized and structurally characterized. The complexes were tested in vitro on human colon and hepatic carcinoma cell lines, normal hepatic cells and hematopoietic progenitor cells. Biological tests proved that Pd(II) complexes 1 and 2 (containing a curcumin derivative) exhibit a strong in vitro antitumor effect against the cells derived from human colorectal carcinoma and the hepatic metastasis of a colorectal carcinoma. Complex 1 has an outstanding inhibitory effect against BRAF-mutant colon carcinoma and hepatocarcinoma cell growth; 1 and 2 are both more active than the free ligand and have the capacity to trigger early apoptotic processes. By flow cytometric measurements, an important decrease of prominin-1 (CD133) molecule expression on tumor cells membrane was identified in cell populations subjected to 1 and 2. Quantitative immune enzymatic assay proved restrictions in stem cell factor (SCF) release by treated tumor cells. Although less cytotoxic, the free ligand inhibits the surface marker CD133 expression in hepatocarcinoma cells, and in HT-29 colon carcinoma. The new synthesized Pd(II) complexes 1 and 2 exhibit an important potential through their selective cytotoxic activity and by targeting the stem-like tumor cell populations, which leads to the tumor growth arrest and prevention of metastasis.
Collapse
|
13
|
Alam MN, Huq F. Comprehensive review on tumour active palladium compounds and structure–activity relationships. Coord Chem Rev 2016. [DOI: 10.1016/j.ccr.2016.02.001] [Citation(s) in RCA: 79] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
14
|
Albert J, Bosque R, Crespo M, Granell J, López C, Martín R, González A, Jayaraman A, Quirante J, Calvis C, Badía J, Baldomà L, Font-Bardia M, Cascante M, Messeguer R. Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I-cathepsin B inhibition. Dalton Trans 2016; 44:13602-14. [PMID: 26140359 DOI: 10.1039/c5dt01713k] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The synthesis and preliminary biological evaluation of neutral and cationic platinum derivatives of chiral 1-(1-naphthyl)ethylamine are reported, namely cycloplatinated neutral complexes [PtCl{(R or S)-NH(2)CH(CH(3))C(10)H(6)}(L)] [L = SOMe(2) ( 1-R or 1-S ), L = PPh(3) (2-R or 2-S), L = P(4-FC(6)H(4))(3) (3-R), L = P(CH(2))(3)N(3)(CH(2))(3) (4-R)], cycloplatinated cationic complexes [Pt{(R)-NH(2)CH(CH(3))C(10)H(6)}{L}]Cl [L = Ph(2)PCH(2)CH(2)PPh(2) (5-R), L = (C(6)F(5))(2)PCH(2)CH(2)P(C(6)F(5))(2) (6-R)] and the Pt(ii) coordination compound trans-[PtCl(2){(R)-NH(2)CH(CH(3))C(10)H(6)}(2)] (7-R). The X-ray molecular structure of 7-R is reported. The cytotoxic activity against a panel of human adenocarcinoma cell lines (A-549 lung, MDA-MB-231 and MCF-7 breast, and HCT-116 colon), cell cycle arrest and apoptosis, DNA interaction, topoisomerase I and cathepsin B inhibition, and Pt cell uptake of the studied compounds are presented. Remarkable cytotoxicity was observed for most of the synthesized Pt(ii) compounds regardless of (i) the absolute configuration R or S, and (ii) the coordinated/cyclometallated (neutral or cationic) nature of the complexes. The most potent compound 2-R (IC(50) = 270 nM) showed a 148-fold increase in potency with regard to cisplatin in HCT-116 colon cancer cells. Preliminary biological results point out to different biomolecular targets for the investigated compounds. Neutral cyclometallated complexes 1-R and 2-R, modify the DNA migration as cisplatin, cationic platinacycle 5-R was able to inhibit topoisomerase I-promoted DNA supercoiling, and Pt(ii) coordination compound 7-R turned out to be the most potent inhibitor of cathepsin B. Induction of G-1 phase ( 2-R and 5-R ), and S and G-2 phases (6-R) arrests are related to the antiproliferative activity of some representative compounds upon A-549 cells. Induction of apoptosis is also observed for 2-R and 6-R.
Collapse
Affiliation(s)
- Joan Albert
- Departament de Química Inorgànica, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1-11, 08028 Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Fanelli M, Formica M, Fusi V, Giorgi L, Micheloni M, Paoli P. New trends in platinum and palladium complexes as antineoplastic agents. Coord Chem Rev 2016. [DOI: 10.1016/j.ccr.2015.11.004] [Citation(s) in RCA: 165] [Impact Index Per Article: 20.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
|
16
|
Albert J, Granell J, Qadir R, Quirante J, Calvis C, Messeguer R, Badía J, Baldomà L, Font-Bardia M, Calvet T. Cyclopalladated Benzophenone Imines: Synthesis, Antitumor Activity, Cell Accumulation, DNA Interaction, and Cathepsin B Inhibition. Organometallics 2014. [DOI: 10.1021/om501060f] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Affiliation(s)
- Joan Albert
- Departament
de Química Inorgànica, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1-11, 08028 Barcelona, Spain
- Institut
de Biomedicina, Universitat de Barcelona, 08028 Barcelona, Spain
| | - Jaume Granell
- Departament
de Química Inorgànica, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1-11, 08028 Barcelona, Spain
- Institut
de Biomedicina, Universitat de Barcelona, 08028 Barcelona, Spain
| | - Romana Qadir
- Departament
de Química Inorgànica, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1-11, 08028 Barcelona, Spain
| | - Josefina Quirante
- Laboratori
de Química Orgànica, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain
- Institut
de Biomedicina, Universitat de Barcelona, 08028 Barcelona, Spain
| | - Carme Calvis
- Biomed Division, LEITAT Technological Center, Parc Científic,
Edifici Hèlix, Baldiri Reixach 15-21, 08028 Barcelona, Spain
| | - Ramon Messeguer
- Biomed Division, LEITAT Technological Center, Parc Científic,
Edifici Hèlix, Baldiri Reixach 15-21, 08028 Barcelona, Spain
| | - Josefa Badía
- Departament
de Bioquímica i Biologia Molecular, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain
- Institut
de Biomedicina, Universitat de Barcelona, 08028 Barcelona, Spain
| | - Laura Baldomà
- Departament
de Bioquímica i Biologia Molecular, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain
- Institut
de Biomedicina, Universitat de Barcelona, 08028 Barcelona, Spain
| | - Mercè Font-Bardia
- Departament
de Crystallografia, Mineralogia i Dipòsits Minerals, Universitat de Barcelona, Martí i Franquès s/n, 08028 Barcelona, Spain
- Unitat
de Difracció de Raigs-X, Centre Científic
i Tecnològic de la Universitat de Barcelona, Solé i Sabarís 1-3, 08028 Barcelona, Spain
| | - Teresa Calvet
- Departament
de Crystallografia, Mineralogia i Dipòsits Minerals, Universitat de Barcelona, Martí i Franquès s/n, 08028 Barcelona, Spain
| |
Collapse
|